RESULTS	Compared with the GB39 control group , patients in the SP6 treatment group showed significant reductions in 5 minutes after treatment in the changes of menstrual pain scores ( 3.03 2.36 versus 0.00 0.29 ; p < 0.001 ) , values of PI ( 0.57 0.42 versus -0.10 0.58 ; p < 0.001 ) , RI ( 0.06 0.08 versus -0.03 0.15 ; p < 0.01 ) , and A/B ( 0.90 0.87 versus 0.23 1.02 ; p < 0.01 ) .\